Evogene Ltd.
EVGN
$0.76
-$0.02-2.05%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 30.96% | -15.96% | 34.62% |
| Total Depreciation and Amortization | -- | -- | -47.13% | -38.11% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -2,828.89% | 486.68% | -60.28% |
| Change in Net Operating Assets | -- | -- | -553.25% | -162.16% | 64.97% |
| Cash from Operations | -- | -- | 8.69% | -17.63% | 39.30% |
| Capital Expenditure | -- | -- | 20.38% | 56.68% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -61.54% | -61.54% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 370.92% | 118.66% | -120.79% |
| Cash from Investing | -- | -- | 312.05% | 106.34% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -5.98% | 25.73% | -67.09% |
| Issuance of Common Stock | -- | -- | -33.45% | -32.72% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.76% | -101.55% | 4.85% |
| Cash from Financing | -- | -- | -74.34% | -73.72% | 86.98% |
| Foreign Exchange rate Adjustments | -- | -- | 80.00% | 134.76% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 33.35% | -253.59% | 21.55% |